▶ 調査レポート

世界の非アルコール性脂肪性肝炎（NASH）薬市場：市場規模・現状・予測
• 英文タイトル：Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の非アルコール性脂肪性肝炎（NASH）薬市場：市場規模・現状・予測 / Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7682資料のイメージです。• レポートコード：QYR9N7682
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、非アルコール性脂肪性肝炎（NASH）薬のグローバル市場について調査・分析したレポートで、種類別（ビタミンEとピオグリタゾン、オベチコール酸（OCA）、エラフィブラノール、Selonsertib＆Cenicriviroc）、用途別（病院薬局、オンラインプロバイダ、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・非アルコール性脂肪性肝炎（NASH）薬の世界市場規模
・主要企業別市場シェア
・非アルコール性脂肪性肝炎（NASH）薬の世界市場規模：種類別（ビタミンEとピオグリタゾン、オベチコール酸（OCA）、エラフィブラノール、Selonsertib＆Cenicriviroc）
・非アルコール性脂肪性肝炎（NASH）薬の世界市場規模：用途別（病院薬局、オンラインプロバイダ、小売薬局）
・非アルコール性脂肪性肝炎（NASH）薬のアメリカ市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬のヨーロッパ市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬の中国市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬の日本市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬の東南アジア市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬のインド市場規模（種類別、用途別）
・非アルコール性脂肪性肝炎（NASH）薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・非アルコール性脂肪性肝炎（NASH）薬の世界市場予測（2019年-2025年）
・非アルコール性脂肪性肝炎（NASH）薬の地域別市場予測（2019年-2025年）
...

Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. However, NASH can become severe and can lead to cirrhosis, in which the liver is permanently damaged.This market is boosted by the growing prevalence of diabetes and obesity, and high investments for research and development, which leads to rising demand for NASH and others nonalcoholic fatty liver diseases (NAFLD) therapies in the market. As per the regional analysis, the well-established healthcare infrastructure with the high adoption rate of new technologies and increasing research activities, makes North America dominate this market.
In 2018, the global Non-Alcoholic Steatohepatitis (NASH) Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-Alcoholic Steatohepatitis (NASH) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Alcoholic Steatohepatitis (NASH) Drugs development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Conatus Pharmaceuticals
Enzo Biochem
Galmed Pharmaceuticals
Genfit
Gilead
Horizon Pharma
Immuron
Intercept Pharmaceuticals
Novo Nordisk

Market segment by Type, the product can be split into
Vitamin E & Pioglitazone
Obeticholic Acid (OCA)
Elafibranor
Selonsertib & Cenicriviroc

Market segment by Application, split into
Hospital Pharmacy
Online Provider
Retail Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-Alcoholic Steatohepatitis (NASH) Drugs status, future forecast, growth opportunity, key market and key players.
To present the Non-Alcoholic Steatohepatitis (NASH) Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-Alcoholic Steatohepatitis (NASH) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Vitamin E & Pioglitazone
1.4.3 Obeticholic Acid (OCA)
1.4.4 Elafibranor
1.4.5 Selonsertib & Cenicriviroc
1.5 Market by Application
1.5.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Online Provider
1.5.4 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size
2.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Growth Trends by Regions
2.2.1 Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Regions (2014-2025)
2.2.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Manufacturers
3.1.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players Head office and Area Served
3.3 Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Product/Solution/Service
3.4 Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019)
4.2 Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
5.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in United States
5.3 United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
5.4 United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

6 Europe
6.1 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
6.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in Europe
6.3 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
6.4 Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

7 China
7.1 China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
7.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in China
7.3 China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
7.4 China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

8 Japan
8.1 Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
8.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in Japan
8.3 Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
8.4 Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
9.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
9.4 Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

10 India
10.1 India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
10.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in India
10.3 India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
10.4 India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size (2014-2019)
11.2 Non-Alcoholic Steatohepatitis (NASH) Drugs Key Players in Central & South America
11.3 Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type
11.4 Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.1.4 AstraZeneca Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Conatus Pharmaceuticals
12.2.1 Conatus Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.2.4 Conatus Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.2.5 Conatus Pharmaceuticals Recent Development
12.3 Enzo Biochem
12.3.1 Enzo Biochem Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.3.4 Enzo Biochem Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.3.5 Enzo Biochem Recent Development
12.4 Galmed Pharmaceuticals
12.4.1 Galmed Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.4.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.4.5 Galmed Pharmaceuticals Recent Development
12.5 Genfit
12.5.1 Genfit Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.5.4 Genfit Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.5.5 Genfit Recent Development
12.6 Gilead
12.6.1 Gilead Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.6.4 Gilead Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.6.5 Gilead Recent Development
12.7 Horizon Pharma
12.7.1 Horizon Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.7.4 Horizon Pharma Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.7.5 Horizon Pharma Recent Development
12.8 Immuron
12.8.1 Immuron Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.8.4 Immuron Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.8.5 Immuron Recent Development
12.9 Intercept Pharmaceuticals
12.9.1 Intercept Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.9.4 Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.9.5 Intercept Pharmaceuticals Recent Development
12.10 Novo Nordisk
12.10.1 Novo Nordisk Company Details
12.10.2 Company Description and Business Overview
12.10.3 Non-Alcoholic Steatohepatitis (NASH) Drugs Introduction
12.10.4 Novo Nordisk Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
12.10.5 Novo Nordisk Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-Alcoholic Steatohepatitis (NASH) Drugs Key Market Segments
Table Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Covered
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Market Share by Type 2014-2025
Figure Vitamin E & Pioglitazone Figures
Table Key Players of Vitamin E & Pioglitazone
Figure Obeticholic Acid (OCA) Figures
Table Key Players of Obeticholic Acid (OCA)
Figure Elafibranor Figures
Table Key Players of Elafibranor
Figure Selonsertib & Cenicriviroc Figures
Table Key Players of Selonsertib & Cenicriviroc
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Online Provider Case Studies
Figure Retail Pharmacy Case Studies
Figure Non-Alcoholic Steatohepatitis (NASH) Drugs Report Years Considered
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2025 (Million US$)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Regions 2014-2019
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Regions 2014-2019
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Manufacturers (2014-2019)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Manufacturers in 2018
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Product/Solution/Service
Table Date of Enter into Non-Alcoholic Steatohepatitis (NASH) Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Share by Type (2014-2019)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Market Share by Type (2014-2019)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Share by Application (2014-2019)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Market Share by Application (2014-2019)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue Market Share by Application in 2018
Figure United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-20189) (Million US$)
Table China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Figure Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share (2018-2019)
Table Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Type (2014-2019)
Table Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Conatus Pharmaceuticals Company Details
Table Conatus Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Conatus Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Conatus Pharmaceuticals Recent Development
Table Enzo Biochem Company Details
Table Enzo Biochem Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Enzo Biochem Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Enzo Biochem Recent Development
Table Galmed Pharmaceuticals Company Details
Table Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Galmed Pharmaceuticals Recent Development
Table Genfit Company Details
Table Genfit Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Genfit Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Genfit Recent Development
Table Gilead Company Details
Table Gilead Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Gilead Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Gilead Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Horizon Pharma Recent Development
Table Immuron Company Details
Table Immuron Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Immuron Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Immuron Recent Development
Table Intercept Pharmaceuticals Company Details
Table Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Intercept Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Intercept Pharmaceuticals Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Non-Alcoholic Steatohepatitis (NASH) Drugs Business (2014-2019)
Table Novo Nordisk Recent Development
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Share by Regions (2019-2025)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Share by Regions in 2025
Figure United States Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Product (2019-2025)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Product in 2025
Table Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application (2019-2025)
Figure Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界のテネクテプラーゼ薬市場：市場規模・現状・予測
    Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8112 2019年6月14日 93Pages
    当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界の糖尿病性網膜症治療薬市場：市場規模・現状・予測
    Global Diabetic Retinopathy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7094 2019年6月14日 93Pages
    当資料は、糖尿病性網膜症治療薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、オプティナ、イルヴィアン、ベタメタゾン、オズルデックス、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...
  • 世界の黄斑変性症の薬市場：市場規模・現状・予測
    Global Macular Degeneration Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7493 2019年6月14日 97Pages
    当資料は、黄斑変性症の薬のグローバル市場について調査・分析したレポートで、種類別（ルセンティス、アイリーア、アバスチン、スクアラミン、Concecept、その他）、用途別（50〜60歳、60〜70歳、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の鼻出血薬市場：市場規模・現状・予測
    Global Epistaxis Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7169 2019年6月14日 99Pages
    当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測
    Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8151 2019年6月14日 99Pages
    当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の不眠症治療薬市場：市場規模・現状・予測
    Global Insomnia Therapeutics Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7372 2019年6月14日 91Pages
    当資料は、不眠症治療薬のグローバル市場について調査・分析したレポートで、種類別（処方、店頭販売（OTC））、用途別（武田薬品工業株式会社、バンダファーマシューティカルズ、メルク社、ファイザー株式会社、テバ製薬工業株式会社、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中...
  • 世界の肝疾患治療薬市場：市場規模・現状・予測
    Global Liver Diseases Therapeutics Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7467 2019年6月14日 104Pages
    当資料は、肝疾患治療薬のグローバル市場について調査・分析したレポートで、種類別（経口、注入）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・肝疾患治療薬の...
  • 世界の一般麻酔薬市場：市場規模・現状・予測
    Global General Anaesthesia Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7230 2019年6月14日 90Pages
    当資料は、一般麻酔薬のグローバル市場について調査・分析したレポートで、種類別（プロポフォール、セボフルラン、イソフルラン、デクスメデトミジン、デスフルラン、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界のリウマチ薬市場：市場規模・現状・予測世界のリウマチ薬市場：市場規模・現状・予測 In 2018, the global Rheumatology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rheumatology Drugs status, future forecast, growth opportunity, key market and key players. The …
  • 世界のノンアルコール飲料市場2019世界のノンアルコール飲料市場2019 The global Non-Alcoholic Beverage market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Non-Alcoholic Beverage market status and forecast, categorizes the global Non-Alcoholic Beverage market size…
  • 世界のノンアルコールビール市場2019世界のノンアルコールビール市場2019 Low-alcohol beer (also called light beer, non-alcoholic beer, small beer, small ale, or near-beer) is beer with little or no alcohol content, which aims to reproduce the taste of beer without the inebriating effects of standard alcoholic brews. Most low-alcohol beers are lagers, but there are some l…
  • 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
  • 世界の骨髄増殖性疾患の薬市場：市場規模・現状・予測世界の骨髄増殖性疾患の薬市場：市場規模・現状・予測 hronic myeloproliferative disorders are rare hematological malignances that involve abnormal accumulation of mature myeloid cells (red blood cells, granulocytes, and platelets) and their precursors (myelocytes, metamyelocytes, nucleated red blood cells, and megakaryocytes) in the peripheral blood an…